{"AllianceGenome": "10906", "HGNC": "10906", "MIM": "601295", "_id": "6555", "_version": 1, "accession": {"genomic": ["AE014294.1", "AH007063.2", "AL161771.17", "CH471085.1", "CP068265.2", "NC_000013.11", "NC_060937.1", "NG_016648.2", "Z54350.1"], "protein": ["AAC51870.1", "AAC95398.1", "AAI30522.1", "AAI30524.1", "AAN16026.1", "CAA91161.1", "EAX09074.1", "NP_000443.2", "Q12908.2"], "rna": ["BC130521.1", "BC130523.1", "NM_000452.3", "U10417.1"], "translation": [{"protein": "NP_000443.2", "rna": "NM_000452.3"}, {"protein": "AAC51870.1", "rna": "U10417.1"}, {"protein": "AAI30522.1", "rna": "BC130521.1"}, {"protein": "AAI30524.1", "rna": "BC130523.1"}]}, "alias": ["ASBT", "IBAT", "ISBT", "NTCP2", "PBAM", "PBAM1"], "ensembl": {"gene": "ENSG00000125255", "protein": "ENSP00000245312", "transcript": "ENST00000245312", "translation": [{"protein": "ENSP00000245312", "rna": "ENST00000245312"}], "type_of_gene": "protein_coding"}, "entrezgene": "6555", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 9.73481837, "exp_mis": 128.5123341, "exp_syn": 67.000203, "lof_z": -1.98911289591705, "mis_z": -3.12758012295201, "mu_lof": 6.37255784792e-07, "mu_mis": 1.11205158891e-05, "mu_syn": 5.69147609164e-06, "n_lof": 16.0, "n_mis": 201.0, "n_syn": 77.0, "p_li": 1.60745645494627e-13, "p_null": 0.99804723424291, "p_rec": 0.00195276575692907, "syn_z": -0.757360590896385}, "bp": 1047, "cds_end": 103718599, "cds_start": 103698482, "n_exons": 6, "nonpsych": {"exp_lof": 8.6871365, "exp_mis": 116.1922535, "exp_syn": 60.5178284, "lof_z": -1.77028150644947, "mis_z": -2.75173859796741, "mu_lof": 6.37255784792e-07, "mu_mis": 1.11205158891e-05, "mu_syn": 5.69147609164e-06, "n_lof": 14.0, "n_mis": 175.0, "n_syn": 73.0, "p_li": 8.88840644644314e-12, "p_null": 0.994845408247225, "p_rec": 0.00515459174388656, "syn_z": -1.01021051584207}, "nontcga": {"exp_lof": 8.94396461, "exp_mis": 118.2192875, "exp_syn": 61.62811345, "lof_z": -2.32743177508278, "mis_z": -3.15160876026633, "mu_lof": 6.37255784792e-07, "mu_mis": 1.11205158891e-05, "mu_syn": 5.69147609164e-06, "n_lof": 16.0, "n_mis": 187.0, "n_syn": 72.0, "p_li": 8.65944711221697e-14, "p_null": 0.998642449619963, "p_rec": 0.00135755037995029, "syn_z": -0.83654789125867}, "transcript": "ENST00000245312.3"}, "exons": [{"cdsend": 103066249, "cdsstart": 103046132, "chr": "13", "position": [[103043997, 103046260], [103049288, 103049446], [103051256, 103051432], [103052619, 103052708], [103058263, 103058382], [103065872, 103066417]], "strand": -1, "transcript": "NM_000452", "txend": 103066417, "txstart": 103043997}], "exons_hg19": [{"cdsend": 103718599, "cdsstart": 103698482, "chr": "13", "position": [[103696347, 103698610], [103701638, 103701796], [103703606, 103703782], [103704969, 103705058], [103710613, 103710732], [103718222, 103718767]], "strand": -1, "transcript": "NM_000452", "txend": 103718767, "txstart": 103696347}], "generif": [{"pubmed": 11535543, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11742882, "text": "There was no apparent correlation between the SLC10A2 polymorphisms and bile acid production or turnover in familial hypertriglyceridemia patients."}, {"pubmed": 12055195, "text": "reglation of the ASBT gene by PPARalpha"}, {"pubmed": 12220224, "text": "role in transport of bile acids in multidrug-resistance-protein 3-overexpressing cells"}, {"pubmed": 15239098, "text": "Positively regulated by retinoic acid. Bile acids induce negative feedback regulation of human ASBT via farnesoid X-receptor-mediated, short heterodimer partner-dependent effect upon retinoic acid receptor/retinoid X receptor activation of ASBT."}, {"pubmed": 15304498, "text": "SLC10A2 expression is regulated by the ubiquitin-proteasome pathway"}, {"pubmed": 15350125, "text": "On the basis of seven transmembrane topology, a three-dimensional model of ASBT is built. The model agrees with available data for pathological mutation P290S because the mutant model after in silico mutagenesis loses the ability to bind bile acids."}, {"pubmed": 15952798, "text": "BIle acid-methanethiosulfonyl can serve as novel and powerful tools to probe the role of endogenous as well as engineered Cys residues in the bile acid binding region(s) of hASBT."}, {"pubmed": 16230354, "text": "current data provide the first evidence that I-BABP is functionally associated with FXR and IBAT in the nucleus and on the membrane, respectively, stimulating FXR transcriptional activity and the conjugated bile acid uptake mediated by IBAT in the ileum"}, {"pubmed": 16237211, "text": "ASBT and ILBP protein were 48% and 67% lower in normal weight gallstone carriers than in controls (P < 0.05); similar differences were found for mRNA expression levels."}, {"pubmed": 16411770, "text": "this study determines a 7TM topology for hASBT and refutes the previously proposed 9TM model"}, {"pubmed": 16749855, "text": "hASBT-mediated prodrug targeting is discussed, including QSAR, in vitro models for hASBT assay, and the current progress in utilizing hASBT as a drug delivery target."}, {"pubmed": 16749860, "text": "Although the presence of a single negative charge was not essential for interaction with hASBT, monoanionic conjugates are favored for hASBT-mediated transport compared to cationic and zwitterionic conjugates."}, {"pubmed": 16899538, "text": "These data suggest that transmembrane segment 7 (TM7) plays a dominant role in the hASBT translocation process."}, {"pubmed": 17942302, "text": "One or more constituents of human serum stimulate ASBT gene expression largely via the down-stream AP-1 response element."}, {"pubmed": 17960397, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18028035, "text": "Extracellular loop 3 amino acids are essential for human ASBT activity as primary substrate interaction points using long-range electrostatic attractive forces."}, {"pubmed": 18063707, "text": "cholesterol content of lipid rafts is essential for the optimal activity of ASBT"}, {"pubmed": 18311924, "text": "involvement of transmembrane domain 4 (TM4) of hASBT in forming the putative translocation pathway. TM4 has distinct helical face that contains residues critical for transport & conformational stability."}, {"pubmed": 18508772, "text": "analysis of how conserved aspartic acid residues lining the extracellular loop 1 of sodium-coupled bile acid transporter ASBT interact with Na+ and 7alpha-OH moieties on the ligand cholestane skeleton"}, {"pubmed": 18644122, "text": "Common variants of the SLC10A2 gene are not associated with sporadic or familial colorectal cancer"}, {"pubmed": 18644122, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18668439, "text": "dysfunction, and impaired adaptive responses of several of the bile acid transporters, e.g. BSEP and ASBT, results in liver and intestinal disease"}, {"pubmed": 18688880, "text": "Cyclic AMP-mediated phosphoinositide-3-kinase{ISBT)-independent activation of Rab4 facilitates Ntcp translocation in a hepatoma cell line."}, {"pubmed": 19184108, "text": "haplotype carriers with the minor allele exhibited significant reduced ileal SLC10A2 expression on mRNA levels (2.6-fold, P = 0.0009) and protein levels (2.4-fold, P = 0.0157)"}, {"pubmed": 19653651, "text": "Integration of results for transmembrane (TM)3 and TM7 cysteine mutants suggests a putative scenario to describe substrate entry and exit into the ASBT permeation pathway during translocation mechanisms."}, {"pubmed": 19823678, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19823678, "text": "SLC10A2 is a novel susceptibility gene for cholelithiasis in humans"}, {"pubmed": 20056894, "text": "Data demonstrate a novel role of lipid rafts in the modulation of ASBT function by the dietary component EGCG, which may underlie the hypocholesterolemic effects of green tea."}, {"pubmed": 20201924, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20346360, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20453000, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20600720, "text": "Results show that bile acid conjugates are potential prolonged release prodrugs with binding affinity for ASBT."}, {"pubmed": 20616306, "text": "These data confirm that bile acids and upregulation of ASBT play a crucial role in NEC pathogenesis and suggest that inhibition of ASBT could be utilized as a therapeutic modality against this disease."}, {"pubmed": 21341987, "text": "the essential role of ASBT in the uptake of bile acids, by which the enterohepatic recirculation of bile acids is maintained"}, {"pubmed": 21526375, "text": "The beneficial effect of rifampicin in cholestasis is associated with an increase in DME expression involved in toxic, bile acid and cholesterol metabolism, as well as a reduction in the bile acid importing system in hepatocytes."}, {"pubmed": 21646357, "text": "data demonstrate that TM1 plays a pivotal role in ASBT function and stability, thereby providing further insight in its dynamic transport mechanism"}, {"pubmed": 21649730, "text": "Presence of multiple functionally relevant variants in SLC10A2 that may influence bile acid homeostasis and physiology."}, {"pubmed": 22016432, "text": "The human ASBT promoter was activated transcriptionally by CDX1 and CDX2."}, {"pubmed": 22093174, "text": "There was no significant association of rs9514089 with gallstone risk, serum lipid parameters and BMI in the Sorbs and in the meta-analysis of all three cohorts. [meta-analysis]"}, {"pubmed": 22403793, "text": "This study provided novel evidence for the alterations in the activity of ASBT by enteropathogenic Escherichia coli infection."}, {"pubmed": 22669917, "text": "ASBT evolved from the earliest vertebrates by gaining affinity for modern bile salts while retaining affinity for older bile salts"}, {"pubmed": 24045943, "text": "Transmembrane domain II of the human bile acid transporter SLC10A2 coordinates sodium translocation."}, {"pubmed": 24498857, "text": "It was conclude that regulation of ASBT expression by resveratrol (RSV) may have clinical relevance with regard to the observed cholesterol-lowering effects of RSV."}, {"pubmed": 25239307, "text": "Data indicate that the lipid flippase (ATP8B1)-transmembrane protein 30A (CDC50A) heterodimer is essential for the apical localization of sodium-dependent bile acid transporter (SLC10A2/ASBT) in Caco-2 cells."}, {"pubmed": 25418280, "text": "The p.Ser267Phe NTCP variant is significantly associated with resistance to chronic hepatitis B and a lower incidence of acute-on-chronic liver failure. Our results support that NTCP is a cellular receptor for HBV in human infection"}, {"pubmed": 25855079, "text": "Results unravel novel roles for N-glycosylation of ASBT and suggest that high levels of glucose alter the composition of the glycan and may contribute to the increase in ASBT function in diabetes mellitus."}, {"pubmed": 25902143, "text": "Data (including data from studies in knockout/transgenic mice) suggest that SLC10A2 is a functional receptor for hepatitis D virus in hepatocytes."}, {"pubmed": 27770636, "text": "Two single-nucleotide polymorphisms at novel loci, rs112404845 (P = 3.8 x 10-8), upstream of COBL, and rs16961023 (P = 4.6 x 10-8), downstream of SLC10A2, obtained genome-wide significant evidence of association with the posterior liability of late-onset Alzheimer's disease in African Americans."}, {"pubmed": 29198943, "text": "A cysteine-less form of hASBT was made by creating point mutations at all 13 endogenous cysteines. Cysless hASBT had significantly reduced function correlated with lowered surface expression.Chemical cross-linking of wild-type and Cysless species revealed that hASBT has a dominant negative effect and exists as an active dimer and/or higher order oligomer with apparently no requirement for endogenous cysteine residues."}, {"pubmed": 31194565, "text": "Study data confirms that tyrosine phosphorylation mediated by Src family kinases (SFKs), in particular, regulates surface expression, function, and stability of hASBT."}, {"pubmed": 31623375, "text": "Results found that, in obesity, intestinal bile acid absorption is increased secondary to increased expression of apical bile acid cotransporter, ASBT, in the brush border membrane of villus cells. The mechanism of stimulation of ASBT expression is likely secondary to increased expression of FXR in these cells."}, {"pubmed": 32071081, "text": "S-acylation modulates the function of the apical sodium-dependent bile acid transporter in human cells."}, {"pubmed": 32162131, "text": "Efficient SNP editing in haploid human pluripotent stem cells."}, {"pubmed": 33189717, "text": "S-acylation status of bile acid transporter hASBT regulates its function, metabolic stability, membrane expression, and phosphorylation state."}, {"pubmed": 33278408, "text": "A Novel Fluorescence-Based Method to Evaluate Ileal Apical Sodium-Dependent Bile Acid Transporter ASBT."}, {"pubmed": 34638773, "text": "Placental Expression of Bile Acid Transporters in Intrahepatic Cholestasis of Pregnancy."}, {"pubmed": 36410025, "text": "Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis."}], "genomic_pos": {"chr": "13", "end": 103066417, "ensemblgene": "ENSG00000125255", "start": 103043998, "strand": -1}, "genomic_pos_hg19": {"chr": "13", "end": 103719196, "start": 103696350, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0006814", "qualifier": "involved_in", "term": "sodium ion transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009617", "qualifier": "involved_in", "term": "response to bacterium"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0015721", "qualifier": "involved_in", "term": "bile acid and bile salt transport"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0015721", "qualifier": "involved_in", "term": "bile acid and bile salt transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0055085", "qualifier": "involved_in", "term": "transmembrane transport"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005902", "qualifier": "located_in", "term": "microvillus"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0016324", "qualifier": "is_active_in", "term": "apical plasma membrane"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 32296183, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008508", "qualifier": "enables", "term": "bile acid:sodium symporter activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008508", "qualifier": "enables", "term": "bile acid:sodium symporter activity"}]}, "homologene": {"genes": [[3702, 817231], [4530, 4325917], [7227, 32621], [7955, 393329], [8364, 100487141], [9031, 428018], [9544, 702376], [9598, 467318], [9606, 6555], [9615, 403448], [9913, 525823], [10090, 20494], [10116, 29500]], "id": 390}, "interpro": [{"desc": "Bile acid:sodium symporter/arsenical resistance protein Acr3", "id": "IPR002657", "short_desc": "BilAc:Na_symport/Acr3"}, {"desc": "Bile acid:sodium symporter", "id": "IPR004710", "short_desc": "Bilac:Na_transpt"}, {"desc": "Sodium/solute symporter superfamily", "id": "IPR038770", "short_desc": "Na+/solute_symporter_sf"}], "ipi": "IPI00030208", "map_location": "13q33.1", "name": "solute carrier family 10 member 2", "other_names": ["Na(+)-dependent ileal bile acid transporter", "Na+/taurocholate cotransporting polypeptide 2", "ileal apical sodium-dependent bile acid transporter", "ileal bile acid transporter", "ileal sodium-dependent bile acid transporter", "ileal sodium/bile acid cotransporter", "sodium/taurocholate cotransporting polypeptide, ileal", "solute carrier family 10 (sodium/bile acid cotransporter family), member 2", "solute carrier family 10 (sodium/bile acid cotransporter), member 2"], "pantherdb": {"HGNC": "10906", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1201406", "ortholog_type": "LDO", "panther_family": "PTHR10361", "taxid": 10090, "uniprot_kb": "P70172"}, {"RGD": "3682", "ortholog_type": "LDO", "panther_family": "PTHR10361", "taxid": 10116, "uniprot_kb": "Q62633"}, {"Ensembl": "ENSGALG00000016858", "ortholog_type": "LDO", "panther_family": "PTHR10361", "taxid": 9031, "uniprot_kb": "E1BSN2"}, {"ZFIN": "ZDB-GENE-040426-1328", "ortholog_type": "LDO", "panther_family": "PTHR10361", "taxid": 7955, "uniprot_kb": "A0A2R8RW10"}, {"WormBase": "WBGene00044650", "ortholog_type": "O", "panther_family": "PTHR10361", "taxid": 6239, "uniprot_kb": "Q33BL1"}, {"FlyBase": "FBgn0030756", "ortholog_type": "O", "panther_family": "PTHR10361", "taxid": 7227, "uniprot_kb": "Q9VXF5"}, {"FlyBase": "FBgn0030638", "ortholog_type": "O", "panther_family": "PTHR10361", "taxid": 7227, "uniprot_kb": "Q9VXV4"}, {"TAIR": "2118021", "ortholog_type": "O", "panther_family": "PTHR10361", "taxid": 3702, "uniprot_kb": "F4JPW1"}, {"TAIR": "2132664", "ortholog_type": "O", "panther_family": "PTHR10361", "taxid": 3702, "uniprot_kb": "Q8VYY4"}, {"TAIR": "2094483", "ortholog_type": "O", "panther_family": "PTHR10361", "taxid": 3702, "uniprot_kb": "Q8RXE8"}, {"TAIR": "2039533", "ortholog_type": "O", "panther_family": "PTHR10361", "taxid": 3702, "uniprot_kb": "Q1EBV7"}, {"TAIR": "2202935", "ortholog_type": "O", "panther_family": "PTHR10361", "taxid": 3702, "uniprot_kb": "Q93YR2"}], "uniprot_kb": "Q12908"}, "pathway": {"kegg": {"id": "hsa04976", "name": "Bile secretion - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-159418", "name": "Recycling of bile acids and salts"}, {"id": "R-HSA-194068", "name": "Bile acid and bile salt metabolism"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-8957322", "name": "Metabolism of steroids"}]}, "pfam": "PF01758", "pharmgkb": "PA318", "pharos": {"target_id": 7673, "tdl": "Tclin"}, "pir": "I38655", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF256483", "relationship": "is"}, {"id": "GNF256484", "relationship": "is"}, {"id": "GNF256485", "relationship": "is"}, {"id": "GNF256486", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF090840", "relationship": "is"}, {"id": "GNF090841", "relationship": "is"}, {"id": "GNF090842", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054816", "relationship": "is"}, {"id": "GNF059597", "relationship": "is"}, {"id": "GNF075012", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF066925", "relationship": "is"}, {"id": "GNF066926", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF095141", "relationship": "is"}, {"id": "GNF134798", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000013.11", "NC_060937.1", "NG_016648.2"], "protein": "NP_000443.2", "rna": "NM_000452.3", "translation": {"protein": "NP_000443.2", "rna": "NM_000452.3"}}, "reporter": {"HG-U133_Plus_2": "207095_at", "HG-U95Av2": "35904_at", "HTA-2_0": "TC13000856.hg.1", "HuEx-1_0": "3523978", "HuGene-1_1": "7972692", "HuGene-2_1": "16780822"}, "summary": "This gene encodes a sodium/bile acid cotransporter. This transporter is the primary mechanism for uptake of intestinal bile acids by apical cells in the distal ileum. Bile acids are the catabolic product of cholesterol metabolism, so this protein is also critical for cholesterol homeostasis. Mutations in this gene cause primary bile acid malabsorption (PBAM); muatations in this gene may also be associated with other diseases of the liver and intestines, such as familial hypertriglyceridemia (FHTG). [provided by RefSeq, Mar 2010].", "symbol": "SLC10A2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1420087"}, "unigene": "Hs.194783", "uniprot": {"Swiss-Prot": "Q12908"}, "wikipedia": {"url_stub": "SLC10A2"}}